Hemo - Trading data on Ortex13 Feb 2024 20:46
Hemogenyx Pharmaceuticals (HEMO), a biotech sector player with a market cap of $50.05 million,
( prior to todays trading )
The stock has exhibited a notable 53.65% upward movement compared to its sector peers over the last month.
Trading activity has surged with the last day's volume reaching 31,492,660 shares, which is significantly beyond the three-month average, marking a 279.9% increase.
Despite this, the company's price performance over the past week shows a decline of 10%. However, its year-to-date price change stands at a robust 46.74%.
The relative strength index (RSI) for HEMO is at 60.17. Recently, the company has seen a spike in news and social media attention within the last 24 hours.
Numbers -
Vol today - 22.6 million
Yesterday 32 million
Friday 129 million
Average 3 month vol -9 million
Very volatile & poor few sessions since RNS
always sceptical regarding market shenanigans especially after such a positive RNS ,
heavy volume , huge spread , delayed large trades , seller in chunks & random posters turn up , mmm …
Orchestrated if sceptical.
Hemo need to toss a CAR T partnership / pharma deal on an RNS backed by Prevail ,
That would certainly suffice & dwarf the recent shenanigans.